These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 16230213)
41. Bronchiolitis: from empiricism to scientific evidence. Carraro S; Zanconato S; Baraldi E Minerva Pediatr; 2009 Apr; 61(2):217-25. PubMed ID: 19322125 [TBL] [Abstract][Full Text] [Related]
42. The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children. Everard ML Curr Opin Allergy Clin Immunol; 2006 Feb; 6(1):56-61. PubMed ID: 16505613 [TBL] [Abstract][Full Text] [Related]
43. Antibiotic use in children is not influenced by the result of rapid antigen detection test for the respiratory syncytial virus. Thibeault R; Gilca R; Côté S; De Serres G; Boivin G; Déry P J Clin Virol; 2007 Jul; 39(3):169-74. PubMed ID: 17532258 [TBL] [Abstract][Full Text] [Related]
53. Rapid detection and clinical features of infants and young children with acute lower respiratory tract infection due to respiratory syncytial virus. Meqdam MM; Subaih SH FEMS Immunol Med Microbiol; 2006 Jun; 47(1):129-33. PubMed ID: 16706795 [TBL] [Abstract][Full Text] [Related]
54. [Cytomegalic virus infection in an infant with jaundice confirmed by virological methods]. Goetz O; Rudkowski Z; Peller P; Rabenda C Pediatr Pol; 1974 May; 49(5):619-21. PubMed ID: 4364520 [No Abstract] [Full Text] [Related]
55. Comparison of in-house PCR, rapid ELISA and NASBA technology for the detection of respiratory syncytial virus in clinical specimen. Tillmann RL; Simon A; Müller A; Schildgen O J Clin Virol; 2008 Feb; 41(2):168-9. PubMed ID: 18024201 [No Abstract] [Full Text] [Related]
56. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada. Paes B; Steele S; Janes M; Pinelli J Curr Med Res Opin; 2009 Jul; 25(7):1585-91. PubMed ID: 19469698 [TBL] [Abstract][Full Text] [Related]
57. [Respiratory syncytial virus: as an etiological agent of respiratory tract infection in children and adults]. Belino-Studzińska P; Pancer K Przegl Epidemiol; 2008; 62(4):767-75. PubMed ID: 19209739 [TBL] [Abstract][Full Text] [Related]
58. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture. Marsh R; Connor A; Gias E; Toms GL J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900 [TBL] [Abstract][Full Text] [Related]